J

Joinn Laboratories China Co Ltd
SSE:603127

Watchlist Manager
Joinn Laboratories China Co Ltd
SSE:603127
Watchlist
Price: 18 CNY 3.15% Market Closed
Market Cap: 11.3B CNY
Have any thoughts about
Joinn Laboratories China Co Ltd?
Write Note

Joinn Laboratories China Co Ltd
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Joinn Laboratories China Co Ltd
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
J
Joinn Laboratories China Co Ltd
SSE:603127
Tax Provision
-ÂĄ82.9m
CAGR 3-Years
-13%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Tax Provision
-ÂĄ1.9B
CAGR 3-Years
-40%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Tax Provision
-ÂĄ322.4m
CAGR 3-Years
-10%
CAGR 5-Years
-32%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Tax Provision
-ÂĄ640.1m
CAGR 3-Years
-11%
CAGR 5-Years
-37%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Tax Provision
-ÂĄ235.9m
CAGR 3-Years
-6%
CAGR 5-Years
-14%
CAGR 10-Years
-22%
W
WuXi XDC Cayman Inc
HKEX:2268
Tax Provision
-ÂĄ76.1m
CAGR 3-Years
-132%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Joinn Laboratories China Co Ltd
Glance View

Market Cap
11.3B CNY
Industry
Life Sciences Tools & Services

Joinn Laboratories China Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Beijing, Beijing and currently employs 2,140 full-time employees. The company went IPO on 2017-08-25. Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The firm conducts its businesses both in the domestic market and overseas markets.

Intrinsic Value
17.31 CNY
Overvaluation 4%
Intrinsic Value
Price
J

See Also

What is Joinn Laboratories China Co Ltd's Tax Provision?
Tax Provision
-82.9m CNY

Based on the financial report for Jun 30, 2024, Joinn Laboratories China Co Ltd's Tax Provision amounts to -82.9m CNY.

What is Joinn Laboratories China Co Ltd's Tax Provision growth rate?
Tax Provision CAGR 5Y
-30%

Over the last year, the Tax Provision growth was 36%. The average annual Tax Provision growth rates for Joinn Laboratories China Co Ltd have been -13% over the past three years , -30% over the past five years .

Back to Top